Trombone Ana Paula F, Silva Celio L, Almeida Luciana P, Rosada Rogerio S, Lima Karla M, Oliver Constance, Jamur Maria C, Coelho-Castelo Arlete A M
Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av, Bandeirantes, 3900, 14049-900, Ribeirão Preto, SP, Brasil.
Genet Vaccines Ther. 2007 Sep 20;5:9. doi: 10.1186/1479-0556-5-9.
This study aimed to demonstrate that microspheres, used as delivery vehicle of DNA-Hsp65/TDM [plasmid DNA encoding heat shock protein 65 (Hsp65) coencapsulated with trehalose dimycolate (TDM) into PLGA microspheres], are widely spread among several organs after intramuscular administration in BALB/c mice. In general, we showed that these particles were phagocytosed by antigen presenting cells, such as macrophages and dendritic cells. Besides, it was demonstrated herein that draining lymph node cells presented a significant increase in the number of cells expressing costimulatory molecules (CD80 and CD86) and MHC class II, and also that the administration of the DNA-Hsp65/TDM and vector/TDM formulations resulted in the up-regulation of CD80, CD86 and MHC class II expression when compared to control formulations (vector/TDM and empty). Regarding the intracellular trafficking we observed that following phagocytosis, the microspheres were not found in the late endosomes and/or lysosomes, until 15 days after internalization, and we suggest that these constructions were hydrolysed in early compartments. Overall, these data expand our knowledge on PLGA [poly (lactic-co-glycolic acid)] microspheres as gene carriers in vaccination strategies, as well as open perspectives for their potential use in clinical practice.
本研究旨在证明,作为DNA-Hsp65/TDM(编码热休克蛋白65的质粒DNA与海藻糖二霉菌酸酯共包封于聚乳酸-羟基乙酸共聚物微球中)递送载体的微球,在BALB/c小鼠肌肉注射后广泛分布于多个器官。总体而言,我们发现这些颗粒被抗原呈递细胞吞噬,如巨噬细胞和树突状细胞。此外,本文还证明引流淋巴结细胞中表达共刺激分子(CD80和CD86)和MHC II类分子的细胞数量显著增加,并且与对照制剂(载体/TDM和空载体)相比,DNA-Hsp65/TDM和载体/TDM制剂的给药导致CD80、CD86和MHC II类分子表达上调。关于细胞内运输,我们观察到吞噬后,直到内化后15天,微球都未出现在晚期内体和/或溶酶体中,我们推测这些结构在早期区室中被水解。总体而言,这些数据扩展了我们对聚乳酸-羟基乙酸共聚物微球作为疫苗接种策略中基因载体的认识,并为其在临床实践中的潜在应用开辟了前景。